Shamburg News · 8-K filed Oct 28, 2026, 5:08 PM EDT
Jaguar Health Supplements Proxy With Share Reserve Adjustment Under 2014 Stock Incentive Plan
JAGX · Jaguar Health, Inc.
- Other event
- Shareholder vote
- Materiality: medium
Jaguar Health, Inc. filed a supplement to its definitive proxy statement for a special stockholder meeting to be held November 6, 2026, disclosing additional information on Proposal 3 to amend and restate its 2014 Stock Incentive Plan to 378,859 shares. The Company stated that its Board approved on October 28, 2026 a six-fold increase in shares available under the 2014 Plan, effective immediately following the Special Meeting, to account for the Series R Preferred Stock dividend and its conversion. Pro forma share reserve figures of 2,273,154 shares if Proposal 3 is approved and 4,260 shares if not were disclosed.
Source: SEC EDGAR, Form 8-K, Item 8.01, accession 0001193125-26-436334.
Written from the filing by Shamburg Markets. Figures are as reported by the company.